Answer
Voriconazole treats invasive aspergillosis, candidaemia in non-neutropenic patients, fluconazole-resistant serious invasive Candida infections (including C. krusei), and serious Scedosporium spp. or Fusarium spp. infections in adults and children aged two years and older, primarily those with progressive, possibly life-threatening infections.
Sources for this answer
- VFEND 200 mg powder for solution for infusionPfizer Limited · emc · SmPC §4.1 Therapeutic Indications · Version 68Document updated
Sources checked